Registry of digestive tumors in Spain
A Descriptive, Multicentre, Observational Epidemiological Study on Digestive Tumours
This study is collecting information on digestive tumors in adults in Spain to see how to improve diagnosis and treatment for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) Academic / other |
| Locations | 1 site (Madrid, Madrid) |
| Trial ID | NCT06711211 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the current state of digestive tumors in Spain, focusing on enhancing the quality of care and optimizing diagnosis and treatment. It will collect data on the epidemiological, biological, and clinical characteristics of digestive tumors diagnosed in patients aged 18 and older across various healthcare centers. The study will gather information from patients diagnosed before and after the study's initiation, and may also collect biological samples for translational research and identification of molecular markers. The goal is to generate scientific evidence that can improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include male and female patients aged 18 and older diagnosed with various types of digestive cancers.
Not a fit: Patients who do not have a diagnosed digestive tumor or cannot provide necessary information for data collection may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and treatment strategies for patients with digestive cancers.
How similar studies have performed: Other observational studies have shown success in improving patient care and outcomes in cancer treatment, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female patients ≥18 years old diagnosed with oesophageal cancer, gastric cancer, pancreatic cancer, hepatocarcinoma, gallbladder and bile duct cancer, cancer of the small intestine, appendix and gastrointestinal stroma, colorectal cancer, anal canal cancer or digestive hereditary cancer. * Written informed consent available. Exclusion Criteria: * Patient for whom, for whatever reason, it is not possible to know or obtain the information necessary to complete the data collection base.
Where this trial is running
Madrid, Madrid
- Grupo de Tratamiento de los Tumores Digestivos (TTD) — Madrid, Madrid, Spain (Recruiting)
Study contacts
- Study coordinator: Esther Mahillo, PhD
- Email: ttd@ttdgroup.org
- Phone: +34913788275
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.